CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase IV, Randomised, Multicentre, Double-blind, Study to Evaluate the Clinical Utility of Prospective Genetic Screening (HLA-B*1301) for Susceptibility to Dapsone Hypersensitivity Syndrome

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02550080
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:16.756339+00:00
Published At: 2017-03-03T00:00:00+00:00
Record Updated At: 2017-03-03
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Allergic Cutaneous Vasculitis", "Urticaria", "Psoriasis", "Acne", "Bullous Skin Diseases", "Sterile Pustulosis", "Leprosy", "Pneumocystis Pneumonia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2017-03-03"
protocolSection.identificationModule.nctId: "NCT02550080"
protocolSection.identificationModule.officialTitle: "A Phase IV, Randomised, Multicentre, Double-blind, Study to Evaluate the Clinical Utility of Prospective Genetic Screening (HLA-B*1301) for Susceptibility to Dapsone Hypersensitivity Syndrome"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.